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Introduction
genes that are inside and outside a gene set. GSVA uses a similar Kolmogorov-Smirnov-like rank statistic 86 to assess the enrichment score, but genes are ranked using a kernel estimation of a cumulative density 87 function [16] . Each of these unsupervised single-sample GSA methods are designed for the analysis of a 88 single dataset. To the best of our knowledge no GSA method exists which integrates and calculates a 89 single sample GSA score on multiple datasets simultaneously. 90 Here, we present a novel unsupervised single-sample gene-set analysis that calculates an integrated 91 enrichment score using all of the information in multiple 'omics datasets. We call this approach multiple 92 omics GSA (moGSA). We show that moGSA has higher sensitivity and specificity to detect gene-sets 93 compared to single dataset GSA and demonstrate that moGSA outperforms existing unsupervised GSA 94 methods when applied to simulated data. We apply moGSA to both small and large scale data from 95 multiple omics studies. 96 may exceed the number of observations. In order to map features to gene-sets, moGSA requires an 114 incidence matrix of gene to gene-set membership associations for each data matrix and in each "gene-115 set annotation matrix", a value of 1 indicates that a feature (e.g. gene) is a member of a gene-set. Rows 116 of the gene-set annotation matrix contain the features and each column is an independent annotation 117 vector for a gene-set. A feature may belong to multiple gene-sets simultaneously, that is a row sum may 118 exceed 1.
6
In the first step, several (k) input data matrices are integrated using multiple factor analysis (MFA) [20] . 120 MFA is a multiple table extension of principal component analysis (PCA) that is well suited to integrating 121 multiple omics data since it reduces high dimensional omics data to a relatively small number of 122 components that capture the most prominent correlated structure among different datasets [20] . To 123 prevent datasets with more features or different scales to dominate a MFA, each dataset is weighted by 124 dividing it by the first eigenvalue of a decomposition of each individual dataset. MFA generates matrices 125 of latent variables (components) in observation (P) and feature (Q) space. The number of components 126 typically equals the number of observations minus one. We retain and examine the first few 127 components as these represent most of the variance in the data. Approaches for choosing the number 128 of components are discussed later. In the next step (step 2) each gene-set annotation matrix (G1..k) is 129 projected as additional information onto the gene-set space (Q1..k) generating a score for each gene-set 130 in the same projected space (W1..k). In the final step (step 3), moGSA multiplies the latent variables of 131 the observations (P) and latent variables of gene-sets (W1..k) to generate a matrix (Y) with a gene-set 132
score (GSS) for each gene-set in each observation (Y). 133
A gene-set with a high GSS value has features that explain a large proportion of the global correlated 134 information among data matrices. These features could be from any or all data matrices, and may be 135 non-overlapping, for example a GSS of a gene set with features A-H, could be driven by high levels of 136 gene expression in genes A,B,C, and increased protein levels in proteins C,D,E and amplifications in copy 137 number in gene H. The GSS matrix (Y) may be decomposed with respect to each dataset (X) or latent 138 variable space (P,Q) so that the contribution of each individual dataset or component to the overall 139 score can be evaluated (see Methods). 140 moGSA outperforms existing single sample GSA methods
141
Methods to perform integrated ssGSA on multiple 'omics datasets are not yet described. Therefore, we 142 compared the performance of moGSA to ssGSA methods that were developed for analysis of one 143 dataset. One-table ssGSA methods were generally optimized for analysis of gene expression data and 144 include the widely used GSVA and ssGSEA and naïve matrix multiplication (NMM) [16, 18] . 145 Figure 2 shows the performance of each method applied to 100 simulated datasets, each run simulated 146 a study of 30 observations with three omics datasets that measured 1,000 features each ( Figure S1 ; see 147
Methods section). Each feature was a member of one of the 20 gene-sets. Each gene-set had 50 genes. 148
The observations were grouped into 6 clusters and each cluster has 5 differentially expressed (DE) (5, 10 and 25 genes). As expected, the performance of all methods was better when signal-to-noise ratio 170 or the number of DE genes in DE gene-sets increased (Figure 2A and 2B) . moGSA consistently 171 outperformed the other methods and the differences were even more apparent when the signal-to-172 noise ratio was low or when there were few DE genes (5 or 10 of 50 genes) ( Figure 2B ). 173
Next we compared the performance of each method using data with a simple or complex phenotype. In 174 data with a simple phenotype a few components should easily capture most of the variance in the data. 175
However in data with a complex phenotype for example a heterogeneous tumor dataset, with mixed 176 histology, grade and response to treatment, there are many signals and many latent variables may be 177 required to capture even half of the variance. Specificity and sensitivity of the methods detecting the DE 178 gene-sets (measured as the area under the receiver operating characteristic curve; AUC) were evaluated. 179
In the simulated data, observations were grouped into six clusters, each with highly correlated genes 180 and these six clusters could be captured by the first five components. Therefore we simulated data such 181 that the first 5 components captured 50%, 30% or only 25% of the total variance ( Figure 2C ). Again, 182 moGSA outperformed the other methods and was relatively robust to changes in the variance retained 183 ( Figure 2D ). The performance (AUC) of all methods decreased when greater variance was retained, 184 which can be explained by higher intra-cluster correlation that leads to a lower signal-to-noise ratio (see 185 methods). 186
Given the many fundamental differences between moGSA and the other ssGSA methods, we repeated 187 the simulations adjusting for technical aspects of the moGSA approach that might give it an "unfair 188 edge", but these did little to improve the performance of the others methods. Since, GSVA and ssGSEA 189
were designed for analysis of single datasets, we compared the performance of GSVA and ssGSEA on a 190 single datasets of the triplet compared to the concatenated triplet. Concatenating multiple data 191 matrices neither improved nor decreased the performance compared to analysis of single datasets, 192 most likely because the signal-to-noise ratio increased accordingly with concatenation ( Figure S2 ). In 193 addition, since MFA weights input matrices by their first singular value before moGSA, we examined the 194 effect of data set weighting on the other methods, but found moGSA still outperformed ssGSEA and 195 GSVA when data matrices of the triplet were weighted before concatenation ( Figure S3 ). 228 GO terms (out of 825) that had significant up or down-regulated gene-set scores (GSSs) in at least 225 one cell line (BH corrected p value < 0.01). There was gene overlap among many GO terms and 226 hierarchical clustering analysis (Hamming distance and complete linkage) was used to group the 288 GO 227 terms into 21 broad categories (Table S1 ). Gene-set scores of representative GO terms from each 228 category are shown in Figure 3A . Biological processes associated with more differentiated cell types 229
were associated with the NFF cells and included up-regulation of vesicle-mediated transport, immune 230 related responses and cell adhesion. In contrast cell proliferation GO terms such DNA replication, and 231 cell cycle processes had significantly higher GGS in the highly proliferative stem cell lines. These results 232 confirm previous findings [21] . 233
In integrative analysis of multiple omics data, it is important to evaluate the relative contribution (either 234 concordant or discrepant) of each dataset to the overall GSS. Data-wise decomposition of the GSSs (see 235 Methods) are shown in Figure 3B . The three data sets have concordant contributions to most of the GO 236 terms, including vesicle mediate transport, cell matrix adhesion, cell cycle processes in NFF line; 237 chromosome organization and biogenesis in H9 and NFF cell lines. 238
However, in other GO classes, we also observed differences in the contribution of mRNA, proteins and 239 phosphor-protein data to the GSS. Chromosome organization and biogenesis had significant positive GSS 240 in the stem cells and significant negative GSS in the NFF cells, and was driven by differences in the 241 phosphorylation data. Another case where the mRNA and protein data were incongruent was the GO 242 class "glycoprotein metabolic process". It had GSS scores of 9.7 (p<0.001), -8.6 (p<0.01), -5.3 (p<0.01) 243 and 0 (p>0.05) in NFF, iPSC, H9 and H1 cells respectively. Up-regulation in NFF mainly reflects up-244 regulation on the protein level. However, down-regulation in iPSC DF19.7 cells is due to low expression 245 of related mRNAs. The GO term wound healing has previously been shown to be differentially 246 upregulated in fibroblast NFF cells compared to ESC [21] . Consistently, we also found wound healing was 247 upregulated in NFF compared to ESC; the GSS for wound healing were 14.2 (p<0.01), -5.4 (p<0.01), -5.2 248 (p<0.01) and -3.6 (p<0.001) for NFF, iPSC, H9 and H1 cells respectively (Table S1 ). Down-regulation of 249 wound healing in H9 cell line was dominated by mRNA data, and the two proteomics datasets 250 contributed little to the negative GSS. In contrast to previous studies [21], we did not observe significant 251 differences in wound healing between iPSC and ESC. This difference could be because moGSA is more 252 sensitive (than single data GSA) in detecting gene-sets that have subtle but consistent changes in 253 multiple datasets. More importantly, the contribution of individual gene-set could be evaluated by the 254 decomposition of GSS with respect to datasets 255
Application of moGSA to TCGA Bladder cancer data analysis 256
Since moGSA performs unsupervised integrative single sample GSA, it is particularly useful approach for 257 cluster discovery in multi 'omics data. Therefore we applied moGSA to extract an integrative subtype 258 model of BLCA from copy number variation (CNV) and mRNA data of 308 muscle invasive urothelial 259 bladder cancer (BLCA) patients (obtained as part of the TCGA project). 260
BLCA is a molecularly heterogeneous cancer with between 2 and 5 molecular subtypes (reviewed by 261 Data were downloaded from the TCGA website and after filtering out features with low variance (see 267 Methods), CNV and RNA-seq mRNA expression data contained 12,447 and 14,710 genes respectively, in 268 which 7,644 genes were common to both datasets ( Figure S4 ). Filtering of features is not required by 269 moGSA but we filter low quality features as they are unlikely to contribute to the analysis. PCA of each 270 individual dataset is shown in Figure S7 . From scree plots of the first 10 eigenvalues, an elbow in each 271 plot appears between 4-6 components suggesting this number of components are needed to capture 272 most of the variance ( Figure S7 ), which we anticipated given the known molecular heterogeneity in 273 these data. The first eigenvalue (square of singular value) of the PCA of BLCA mRNA and CNV data are 274 0.0004 and 0.0003 respectively. We applied a preliminary MFA on the data and Figure 4A shows the 275 eigenvalues of the resulting components. The top five components captured a quarter of the total 276 variance and were not dominated by either CNV or mRNA (CNV 50.6%, mRNA 49.4% Figure S16 ). 295
In a typical analysis, we use a scree plot to select the number of components. The scree plot indicated 296 that five components should capture sufficient variance for input to moGSA. We confirmed that this was 297 the optimal number of components as input to moGSA, in the following experiment. We performed 298 moGSA on the BLCA mRNA gene expression and CNV data (n=308) with a number of components ranged 299 from 1 to 12. For each gene-set in the GSS matrix, gene-sets were ranked by the number of tumors in 300 which they were significantly regulated (either positive or negative GSS, p<0.05), such that gene-sets 301 that were significant in most tumors had highest rank. The distribution of the number of tumors in 302 which gene-sets were significant at p<0.05, p<0.01, and p<0.001 is shown Figure and therefore in parallel, we also used the "prediction strength" algorithm, to discover the number of 321 stable subtypes that can be predicted from the data [27] (see Methods). Data were divided into training 322 14 and test, and a KNN classifier was used to iteratively predict the class of each patient. Though no good 323 choice of K existed ( Figure S12 ), this had minimal influence on the final result, which clearly supported 324 three subtypes ( Figure S13 ). Therefore using two independent approaches, we determined that the data 325 
in (C). (D-F) Same as (A-C) for "G protein couple receptor activity". Gene names in (F) with 333
asterisks indicate genes from CNV data. 334
The three BLCA subtypes identified in our integrative analysis overlapped with the BLCA subtypes 335 identified in previous studies (Table S2, Figure S14 ). Our integrative BLCA subtypes consisted of two 336 larger subtypes C1, C2 containing 148 and 103 patients respectively, and a smaller group C3 with 57 337 patients. The smaller subtype, C3, was the most robust ( Figure S10E, S11) (Table S2) . Accordingly, we observed higher 344 mutation rate in the C2 patients ( Figure S15 ). In single sample gene-set analysis with moGSA, C1 patients 345 had more significant GSS (p<0.05) than C2 or C3 ( Figure S16) . 346
To further characterize BLCA, we focused on gene-sets that were differentially regulated in most 347
patients. There were 73 gene-sets that were significantly regulated (positive or negative GSS, p 348 value<0.05) in 200 or more of the 308 patients (Table S3 and Figure S17 The remaining 20 gene-sets in the C1 cluster of gene-sets included terms associated with "extracellular", 359 function, cell morphogenesis, migration and muscle cell development, "apoptosis" (2 gene-sets), and "G 360 protein coupled receptor" (6 gene-sets) (Figure S17, S18) and EMT related gene sets ( Figure S19 ), which 361 recent reports that the Basal-like subtype tend to have more muscle-invasive and metastatic disease at 362 presentation [22] . The remaining gene-sets could broadly be defined by biological processes of "cell 363 cycle" (9 gene-sets) and "DNA repair and chromosome related" (7 gene-sets) which had high GSS in C2 364 (and some C1) and "mitochondrion" (4 gene-sets) in C3. A heatmap of the GSSs of representative gene-365 set of each category is shown in Figure 4C and S17. We found that most of these gene-sets have been 366 associated with subtype of bladder cancer. Increased cell-cycle and DNA repair GSS were associated 367 with the "genomically unstable" luminal C2 cluster [28] (Figure S14, S16) . The mitochondrial component 368 has been described in bladder cancer and other cancers previously [28, 29], our study particularly 369 associated this function with C3 low-grade papillary-like subtype in BLCA. However other gene-sets may 370 be associated with C3 that were excluded when GSS were filtered to those that were broadly significant 371 in 200 or more patients. 372
The GSSs clearly distinguished the three BLCA molecular subtypes. The most significant gene-sets, 373 "immune response" and "immune system process" have significant positive or negative GSS in 270 and 374 265 of 308 patients respectively (Table S3 ). The median GSS for the gene-set "immune system process" 375 was 0.82, -0.75, -0.61 in C1, C2 and C3 respectively (Figure S17, S18) indicating that immune related 376 processes have high gene expression or CNV in the C1 subtype and much lower in C2 and C3. Next, we 377 determined the importance of individual genes in each gene-set by calculating a gene influential score 378 (GIS) using a leave-one-out procedure (see methods). The maximum GIS value for a gene in a gene-set is 379 1, which indicates that gene contributes a high proportion of variance to the overall variance of the GSSs. 380
A GIS close to 1 often suggests a high correlation between the gene expression value and GSS. Gene 381 influential score of the gene-set immune system process in BLCA suggested that the top ranked genes 382 included ITGB2, SPI1, DOCK2, LILRB2 and LAT2. Other highly ranked genes included drug target genes 383 such as CD4, IL6, the interferon induced proteins IFITM2 and IFITM3 and the G protein coupled 384 receptors GPR183 and CMKLR1 (Table S4 ). Top positive influencers in "regulation of apoptosis" were 385 also related to the immune response, such as STK17A, ANXA5 and BCL2A1, STAT1, Serpin B, TGFB and 386 ANXA1 (Table S4) . Moreover, several epithelial to mesenchymal transition (EMT) related gene-sets, such 387 as "collagen" (including COL6A3, COL1A1, COL5A1 and COL3A1), "extracellular matrix proteins" (e.g. 388 glycoproteins SRGN and FBN1) and mesenchymal gene-sets were elevated in C1 ( Figure S19 ; Table S4 ). 389
The C3 subtype tumors had higher GSSs in mitochondrial related gene-set and lower expression of genes 390 related to cell cycle process and DNA replication. GIS analysis suggested that two families of genes, 391 NADH dehydrogenases (NDUFs) and mitochondrial ribosomal proteins (ABCC1/MRP) influenced the 392 mitochondrial proteins (Table S4) . 393
To identify transcription factors (TF) that may regulate gene expression in the three tumor subtypes, we 394 used transcriptional factor target (TFT) gene-sets to annotate the tumors. Similar to the selection of GO 395 terms, we focused on TFT gene-sets with more than 200 significant GSSs across 308 patients (Table S2) . 396
The GSSs of the E2F family target gene-set were significantly different in most of the tumors and are 397 particularly low for the C3 tumors. The rest of the four identified TFs were highly elevated in the C1 398 subtype. Among them, we identified an MADS (MCM1, Agamous, Deficiens, and SRF) box superfamily 399 member, SRF and several TFs associated with transactivation of cytokine and chemokine genes, 400 including NFkB1, ETS1 and IRF1 ( Figure 4D ). The genes exhibiting the largest GIS in the IRF1 and NFkB1 401 target gene-sets include ACTN1, CXorf21, ICAM1, MSN, TNFSF13B, IL12RB1 and CDK6 (Table S5) . Further, 402 we examined the correlations between GSSs and the mRNA expression. All five TFs showed that the TF 403 mRNA and GSSs are significantly correlated ( Figure 4E, Figure S20 ). The boxplot of GSS with respect to 404 subtypes in Figure 4C and D are shown in Figure S18 ,S21. 405
In order to identify the contribution of each dataset, we decomposed the GSSs with respect to the 406 datasets or components. Figure 5A shows the means of data-wise decomposed GSSs in each subtype for 407 "cell cycle process", where we found that mRNA expression strongly influenced the GSS, particularly the 408 low GSS of the C3 subtype patients. The gene influential score (GIS) analysis supports this finding as the 409 top 30 most influential genes are all based on mRNA expression ( Figure 5B ), including RACGAP1, DLGAP5, 410 FBXO5, AURKA, KERA (CNA2) and CDKN3 ( Figure 5C ). By contrast, both CNV and mRNA data influenced 411 the gene-set "G protein coupled receptor activity" ( Figure 5D ) and the GIS analysis shows that the most 412 influential genes include those from both mRNA and CNV data ( Figure 5E ). However, the CNV and mRNA 413 expression patterns in the C3 subtype shows a clear difference for this gene-set ( Figure 5F ). Top gene 414 influencers of "G protein couple receptor activity" included CNV of GRM6, NMUR2, PDGFRB and 415 adrenergic receptors, the gene expression of ADGRL4 (ELTD1), CMKLR1 and PDGFRB ( Figure 5F ). In 416 addition, the data-wise decomposition of GSS identified several GSSs that were only contributed by the 417 mRNA data, including the immune system process, DNA replication and mitochondrion gene-set (Figure  418 S21). 419
Discussion

420
In this paper, we introduced a new multivariate single sample gene-set analysis approach, moGSA that 421 enables discovery of biological pathways with correlated profiles across multiple complex datasets. 422 moGSA uses multivariate latent variable analysis to explore correlated global variance structure across 423 datasets and then extracts the set of gene-sets or pathways with highest variance and most strongly 424 associated with this correlated structure across observations. By combining multiple data types, we can 425 compensate for missing or unreliable information in any single data type so we may find gene-sets that this is rare in MFA, because it focuses on components that capture global correlation among all datasets. 471
Often batch effects are specific to a platform and thus a component that captures information that is 472 entirely uncorrelated to the global structure will be omitted from the set of highly variant integrated 473 components. However it is still wise to perform careful batch effect control, especially in the large scale 474 omics studies. A more detailed description of batch effect detection is described in [34] . 475
Another consideration when applying moGSA, is that it is most efficient in detecting gene-sets that have 476 broad correlation patterns among data types. It may fail to discover gene-sets with few genes, 477 particularly if they had low variances on the selected components. The first step of the moGSA involves data integration with a multiple table multivariate analysis method. 494
In this study, we use MFA because of its simplicity and computational efficiency. MFA can be viewed as a 495 generalization of principal component analysis (PCA) for a multi-table problem [20] . We briefly describe 496 MFA using the nomenclature of Abdi et al. 2013 [20] . 497
When integrating multiple data matrices, one must decide if all datasets should have equal weights, or if 498 some data are "more important", for example those with higher quality, fewer features, higher variance, 499 etc. Simple tensor decomposition approaches, or PCA on a concatenated matrix, give every dataset 500 equal weights and results are often dominated by the matrix (or matrices) with the large variance or 501 most features. To correct for this, MFA weights datasets by dividing each by their first eigenvalue. The 502 weight of each matrix is expressed as 503
Where 2 1 k，  is the first singular value of data matrix Xk. For convenience, the weights of matrices are 504 stored in a diagonal matrix A, whose diagonal elements are 505
The transpose of a matrix is denoted by superscript T .
1k
T is a vector of 1 in the length of pk. As a result, A 506 is a p×p diagonal matrix, the diagonal elements of A representing the weight of features in X1, ..., Xk. 507
Similarly, the weight of each observation is an n×n diagonal matrix, M. In the present study, we use 508 mii=1/n, namely, all observations are equally weighted. 509
We then transpose and concatenate all Xk to a complete pxn matrix ( ): 510
After deriving the matrix weights, observation weights and the concatenated matrix, MFA is reduced to 511 an analysis of the triplet (X, A, M) . The solution of the problem is given by generalized singular value 512 decomposition (GSVD): 513
with the constraint that
X is transpose so that P is a n×r matrix, Q is a p×r matrix, Δ is an r×r square matrix, the maximum 514 number of r is the rank of X. The components of MFA, F, are given by 515
where F has the same dimension as P. In the PCA framework, the matrix P contains the PCs or latent 516 variables. We also call it sample space in this paper. The column vectors in P may be plotted on a two 517 dimensional space to visualize the contribution of each observation to the variance captured by each PC. 518
The matrix Q is the loading matrix or gene space. Because X is a concatenation of multiple matrices, the 519 gene space matrices Q1, ..., Qk may also be concatenated or partitioned in the same manner, namely, 520 where
Ĝ is the grand annotation matrix with dimension p×m. The overall gene-set space W (m×r matrix) could 532 also be expressed as the sum of individual ^ and Qk , that is, 533
moGSA step 3 reconstruction of gene-set-observation matrix 535
The main output of MOGSA is a gene-set score (GSS) matrix, denoted by Y, whose rows are m gene-sets 536 and columns are n observations. It is calculated as 537
where Q [R] and P [R] are the gene space and observation space within top R components.
] [ R Δ is the 538 diagonal matrix containing top R singular values. As a result, X [R] is the reconstruction of X using top R 539 components. In practice, it is interesting to evaluate the contribution of a dataset or a component to the 540 overall gene-set score. Therefore, we decompose gene-set scores with respect to data sets and 541 components. The GSS matrix for dataset Xk and component r is calculated as 542
we use superscript r to indicate the rth component and the subscript k to indicate the kth matrix (Xk). The expression (7) and (10) say that, for each observation, a gene-set score could be viewed as the mean 558 of gene expression (in the reconstructed expression values X [R] ) of genes in a particular gene-set. 559
If the candidate genes in a gene-set are randomly drawn from all features in X [R] (null hypothesis), the 560 distribution of the means of selected genes is given by central limited theorem (CLT), 561
Where is the mean of a column (observation) in X [R] , x  is the sampling standard deviation of means,
562
 is the standard deviation of the column in X [R] , h is the number of candidate genes mapped to X in a 563 gene-set and
is the finite population correction factor (p is the number of features in 564 X). It is used since each gene was only selected once in one gene-set. 565
Gene influential score 566
Gene-sets are composed of genes, and therefore we calculate the contribution of each feature to the 567 GSS, as it is interesting from a biological point of view to identify "driver" genes in a gene-set. In moGSA, 568 feature contribution, denoted by gene influential score (GIS), is calculated via a leave-one-out procedure. 569
The GSS of gene-set i, , for all the observations are 570 standing for low, medium and high signal-to-noise ratio. In total, 100 projects of triplet datasets were 609 generated. The three matrix triplets were analyzed by moGSA. NMM, GSVA and ssGSEA, only accept one 610 matrix as input; therefore the three simulated matrices in one triplet set were concatenated. The 611 performance was assessed by the area under the ROC curve (AUC). 612
